David Hudesman, MD, discusses why some patients with inflammatory bowel disease may fail their medication and how gastroenterologists can approach this, and other challenges associated with managing...
Thomas Seck, MD, from Boehringer Ingelheim, spoke with us about the results of the landmark EMPA-REG OUTCOME trial and what they mean for the treatment of diabetes and cardiovascular disease.
<p>Scott Zellner, from DePuy Synthes, discusses the Anterior Approach, why its a growing trend, and why its a better surgical option for patients.</p>
Sharon Donovan, PhD, RD, from the University of Illinois and American Society for Nutrition, discusses new recommendations for food allergies in children.
<p>Dr Kevin Maki, from Midwest Biomedical Research, speaks to us about his latest review about the effect of omega3 supplementation on cardiometabolic health.</p>
Quinn Pack, MD, from Tufts University, explains his study about the prescription of smoking cessation therapies after hospitalization for coronary heart disease.
<p>Dr Elliott Fegelman, from Johnson &amp;&nbsp;Johnson, discusses the role of research for the future of bariatric surgery and what lies ahead for Project Game Changer.</p>
<p>Dr Elliott Fegelman, from Johnson &amp; Johnson, discusses bariatric surgery as a treatment for cardiometabolic conditions, the risks and benefits of surgery, as well as the research that has...